Healthcare Sector Stocks
The Healthcare sector has a total of 1054 stocks, with a combined market cap of $8.89 trillion, total revenue of $4.59 trillion and a weighted average PE ratio of 44.73.
Market Cap
8.89T
Revenue
4.59T
Profits
198.75B
PE Ratio
44.73
Profit Margin
4.33%
Dividend Yield
0.39%
1054 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | 0.35% | 2,552,230 | 72.25B |
| 2 | JNJ | Johnson & Johnson | 594.63B | -2.69% | 10,547,296 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 431.29B | 0.44% | 6,388,965 | 62.82B |
| 4 | UNH | UnitedHealth Group Incorporated | 380.08B | -1.57% | 6,764,792 | 449.71B |
| 5 | MRK | Merck & Co., Inc. | 305.29B | 2.34% | 9,053,781 | 65.77B |
| 6 | NVS | Novartis AG | 276.90B | 0.29% | 1,757,763 | 56.58B |
| 7 | AZN | AstraZeneca PLC | 262.88B | 2.35% | 2,938,307 | 60.44B |
| 8 | NVO | Novo Nordisk A/S | 223.88B | 3.04% | 10,314,858 | 50.57B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 198.93B | 0.23% | 2,088,058 | 45.20B |
| 10 | AMGN | Amgen Inc. | 193.39B | 0.86% | 1,837,924 | 37.22B |
| 11 | GILD | Gilead Sciences, Inc. | 163.51B | 1.28% | 4,467,638 | 29.74B |
| 12 | ABT | Abbott Laboratories | 155.49B | 1.06% | 16,415,340 | 45.13B |
| 13 | DHR | Danaher Corporation | 142.11B | 0.87% | 4,373,206 | 24.78B |
| 14 | PFE | Pfizer Inc. | 141.46B | 2.35% | 44,162,477 | 63.32B |
| 15 | ISRG | Intuitive Surgical, Inc. | 137.76B | 2.50% | 4,141,561 | 10.58B |
| 16 | CVS | CVS Health Corporation | 135.13B | -0.25% | 6,939,634 | 405.62B |
| 17 | SYK | Stryker Corporation | 121.31B | 1.73% | 2,722,237 | 25.27B |
| 18 | VRTX | Vertex Pharmaceuticals Incorporated | 121.09B | 0.16% | 1,192,070 | 12.22B |
| 19 | BMY | Bristol-Myers Squibb Company | 119.91B | 3.11% | 12,485,329 | 48.48B |
| 20 | SNY | Sanofi | 104.69B | 1.16% | 1,964,858 | 54.60B |
| 21 | MDT | Medtronic plc | 103.01B | 1.48% | 8,785,630 | 36.36B |
| 22 | GSK | GSK plc | 102.95B | 0.39% | 2,800,186 | 43.29B |
| 23 | MCK | McKesson Corporation | 93.23B | -0.87% | 664,848 | 403.43B |
| 24 | ELV | Elevance Health, Inc. | 84.76B | -8.54% | 3,897,310 | 201.11B |
| 25 | HCA | HCA Healthcare, Inc. | 84.04B | 4.19% | 2,179,981 | 76.39B |
| 26 | CI | The Cigna Group | 78.78B | -1.83% | 1,655,913 | 277.89B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 67.60B | 1.27% | 555,420 | 14.92B |
| 28 | BSX | Boston Scientific Corporation | 63.97B | 0.96% | 14,531,545 | 20.61B |
| 29 | COR | Cencora, Inc. | 57.70B | -1.89% | 1,280,147 | 328.68B |
| 30 | ARGX | argenx SE | 53.71B | 0.41% | 177,219 | 4.74B |
| 31 | CAH | Cardinal Health, Inc. | 52.68B | -2.25% | 2,358,355 | 250.74B |
| 32 | TAK | Takeda Pharmaceutical Company Limited | 52.09B | 0.37% | 4,757,551 | 28.34B |
| 33 | MDLN | Medline Inc. | 51.81B | 2.02% | 5,879,422 | 29.14B |
| 34 | EW | Edwards Lifesciences Corporation | 50.25B | -3.13% | 8,196,013 | 6.30B |
| 35 | HUM | Humana Inc. | 48.96B | 0.25% | 1,565,885 | 137.20B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 43.94B | 3.02% | 953,300 | 4.45B |
| 37 | HLN | Haleon plc | 42.68B | 0.52% | 4,054,204 | 14.85B |
| 38 | BDX | Becton, Dickinson and Company | 42.68B | 2.81% | 1,992,844 | 22.23B |
| 39 | NTRA | Natera, Inc. | 39.72B | 1.73% | 867,755 | 2.50B |
| 40 | RVMD | Revolution Medicines, Inc. | 39.21B | -0.29% | 1,538,128 | - |
| 41 | A | Agilent Technologies, Inc. | 38.05B | -0.36% | 1,909,132 | 7.23B |
| 42 | ALNY | Alnylam Pharmaceuticals, Inc. | 37.27B | -0.75% | 1,284,941 | 4.29B |
| 43 | WAT | Waters Corporation | 36.81B | -0.39% | 567,580 | 3.77B |
| 44 | TEVA | Teva Pharmaceutical Industries Limited | 36.75B | -0.82% | 5,519,683 | 17.35B |
| 45 | ONC | BeOne Medicines AG | 34.60B | 1.53% | 636,544 | 5.74B |
| 46 | IQV | IQVIA Holdings Inc. | 34.52B | -0.49% | 1,143,660 | 16.63B |
| 47 | ALC | Alcon Inc. | 33.48B | 2.45% | 2,629,299 | 10.63B |
| 48 | CNC | Centene Corporation | 32.89B | -3.07% | 4,411,715 | 178.33B |
| 49 | RPRX | Royalty Pharma plc | 32.43B | 1.15% | 2,749,372 | 2.44B |
| 50 | VEEV | Veeva Systems Inc. | 31.46B | 0.30% | 1,391,331 | 3.32B |
| 51 | ZTS | Zoetis Inc. | 31.25B | 0.62% | 5,359,545 | 9.53B |
| 52 | BIIB | Biogen Inc. | 29.12B | 2.76% | 2,067,351 | 9.94B |
| 53 | GEHC | GE HealthCare Technologies Inc. | 28.75B | 2.50% | 6,773,282 | 20.98B |
| 54 | RMD | ResMed Inc. | 28.64B | 2.88% | 1,208,785 | 5.54B |
| 55 | ILMN | Illumina, Inc. | 28.32B | -2.12% | 1,782,479 | 4.39B |
| 56 | DXCM | DexCom, Inc. | 28.06B | -1.88% | 4,160,830 | 4.82B |
| 57 | MRNA | Moderna, Inc. | 27.09B | 1.25% | 3,427,826 | 2.23B |
| 58 | MTD | Mettler-Toledo International Inc. | 26.60B | 0.13% | 139,781 | 4.09B |
| 59 | PHG | Koninklijke Philips N.V. | 25.86B | 3.68% | 1,150,412 | 20.34B |
| 60 | WST | West Pharmaceutical Services, Inc. | 25.36B | 0.38% | 496,677 | 3.22B |
| 61 | ROIV | Roivant Sciences Ltd. | 25.10B | -0.06% | 2,555,835 | 8.26M |
| 62 | INSM | Insmed Incorporated | 23.80B | -0.27% | 2,116,814 | 819.56M |
| 63 | BNTX | BioNTech SE | 23.26B | 1.76% | 761,876 | 3.23B |
| 64 | INCY | Incyte Corporation | 22.99B | 0.18% | 1,564,845 | 5.36B |
| 65 | UTHR | United Therapeutics Corporation | 22.57B | 0.97% | 448,060 | 3.17B |
| 66 | DGX | Quest Diagnostics Incorporated | 22.34B | -2.05% | 1,193,177 | 11.28B |
| 67 | LH | Labcorp Holdings Inc. | 22.30B | -1.34% | 809,589 | 14.14B |
| 68 | GH | Guardant Health, Inc. | 21.61B | 1.78% | 1,549,260 | 1.08B |
| 69 | STE | STERIS plc | 20.61B | 1.31% | 780,641 | 5.94B |
| 70 | VTRS | Viatris Inc. | 19.42B | 2.27% | 7,965,464 | 14.56B |
| 71 | GMAB | Genmab A/S | 17.81B | 1.22% | 1,744,239 | 3.90B |
| 72 | ZBH | Zimmer Biomet Holdings, Inc. | 17.44B | -0.98% | 2,495,255 | 8.41B |
| 73 | NBIX | Neurocrine Biosciences, Inc. | 17.30B | 0.01% | 878,504 | 3.10B |
| 74 | ASND | Ascendis Pharma A/S | 16.68B | 1.13% | 441,977 | 998.25M |
| 75 | THC | Tenet Healthcare Corporation | 16.57B | 4.71% | 1,550,711 | 21.46B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 16.20B | -1.70% | 1,955,282 | 579.96M |
| 77 | MEDP | Medpace Holdings, Inc. | 15.11B | -1.29% | 283,062 | 2.68B |
| 78 | JAZZ | Jazz Pharmaceuticals plc | 15.03B | 0.53% | 610,536 | 4.44B |
| 79 | DVA | DaVita Inc. | 14.87B | -0.34% | 462,937 | 13.84B |
| 80 | BTSG | BrightSpring Health Services, Inc. | 14.22B | -2.02% | 5,848,553 | 13.65B |
| 81 | EXEL | Exelixis, Inc. | 13.96B | -0.39% | 1,895,910 | 2.38B |
| 82 | COO | The Cooper Companies, Inc. | 13.77B | 3.05% | 1,945,644 | 4.23B |
| 83 | SOLV | Solventum Corporation | 13.57B | 2.74% | 846,200 | 8.26B |
| 84 | ICLR | ICON Public Limited Company | 13.18B | 2.45% | 460,338 | 8.27B |
| 85 | SNN | Smith & Nephew plc | 13.07B | 3.25% | 2,676,504 | 6.16B |
| 86 | ALGN | Align Technology, Inc. | 12.98B | 1.57% | 604,850 | 4.10B |
| 87 | FMS | Fresenius Medical Care AG | 12.80B | -0.33% | 537,884 | 22.32B |
| 88 | ELAN | Elanco Animal Health Incorporated | 12.76B | -0.04% | 4,089,178 | 4.89B |
| 89 | MDGL | Madrigal Pharmaceuticals, Inc. | 12.69B | 2.49% | 264,310 | 1.13B |
| 90 | PEN | Penumbra, Inc. | 12.46B | 0.15% | 371,504 | 1.45B |
| 91 | RVTY | Revvity, Inc. | 12.42B | 0.13% | 836,105 | 2.90B |
| 92 | AXSM | Axsome Therapeutics, Inc. | 12.22B | 0.96% | 838,870 | 708.24M |
| 93 | MOH | Molina Healthcare, Inc. | 12.16B | -3.39% | 1,320,485 | 43.10B |
| 94 | ABVX | ABIVAX Société Anonyme | 11.81B | 1.50% | 934,624 | 5.67M |
| 95 | SMMT | Summit Therapeutics Inc. | 11.70B | -2.59% | 2,302,869 | - |
| 96 | BAX | Baxter International Inc. | 11.44B | 1.61% | 5,022,272 | 11.32B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 11.39B | 0.53% | 908,054 | 3.24B |
| 98 | CYTK | Cytokinetics, Incorporated | 11.22B | 0.84% | 1,334,079 | 105.82M |
| 99 | TECH | Bio-Techne Corporation | 11.14B | 0.35% | 3,187,304 | 1.21B |
| 100 | PODD | Insulet Corporation | 11.03B | 0.10% | 1,332,051 | 2.90B |
| 101 | CRL | Charles River Laboratories International, Inc. | 10.99B | -1.29% | 860,628 | 4.03B |
| 102 | EHC | Encompass Health Corporation | 10.90B | 1.06% | 811,271 | 6.07B |
| 103 | GMED | Globus Medical, Inc. | 10.66B | 3.61% | 1,481,159 | 3.10B |
| 104 | RDY | Dr. Reddy's Laboratories Limited | 10.64B | -0.55% | 1,867,362 | 3.58B |
| 105 | KRYS | Krystal Biotech, Inc. | 10.32B | 3.18% | 381,177 | 417.30M |
| 106 | TEM | Tempus AI, Inc. | 10.28B | -2.42% | 2,772,231 | 1.36B |
| 107 | ARWR | Arrowhead Pharmaceuticals, Inc. | 10.12B | -0.13% | 1,863,849 | 622.01M |
| 108 | APGE | Apogee Therapeutics, Inc. | 10.06B | 0.25% | 607,392 | - |
| 109 | HSIC | Henry Schein, Inc. | 9.93B | 0.29% | 1,209,719 | 13.38B |
| 110 | NUVL | Nuvalent, Inc. | 9.83B | - | - | - |
| 111 | ENSG | The Ensign Group, Inc. | 9.70B | 0.39% | 462,282 | 5.27B |
| 112 | CORT | Corcept Therapeutics Incorporated | 9.62B | -0.99% | 1,019,944 | 769.10M |
| 113 | KYMR | Kymera Therapeutics, Inc. | 9.39B | 1.82% | 414,654 | 51.48M |
| 114 | OSCR | Oscar Health, Inc. | 9.22B | -1.48% | 3,870,135 | 13.30B |
| 115 | GKOS | Glaukos Corporation | 9.21B | 2.88% | 630,561 | 551.35M |
| 116 | IONS | Ionis Pharmaceuticals, Inc. | 9.04B | -0.36% | 3,577,546 | 1.06B |
| 117 | HALO | Halozyme Therapeutics, Inc. | 8.99B | 1.03% | 1,339,964 | 1.51B |
| 118 | SYRE | Spyre Therapeutics, Inc. | 8.98B | 3.15% | 1,520,637 | - |
| 119 | UHS | Universal Health Services, Inc. | 8.96B | 2.63% | 795,285 | 17.76B |
| 120 | BRKR | Bruker Corporation | 8.93B | -1.96% | 1,920,725 | 3.46B |
| 121 | PRAX | Praxis Precision Medicines, Inc. | 8.88B | -2.83% | 253,559 | 7.46M |
| 122 | CRNX | Crinetics Pharmaceuticals, Inc. | 8.85B | 0.23% | 3,531,274 | 18.07M |
| 123 | PTGX | Protagonist Therapeutics, Inc. | 8.71B | 3.19% | 836,109 | 74.06M |
| 124 | ALKS | Alkermes plc | 8.66B | 0.74% | 1,556,271 | 1.56B |
| 125 | HIMS | Hims & Hers Health, Inc. | 8.60B | 5.75% | 14,427,645 | 2.37B |
| 126 | QGEN | Qiagen N.V. | 8.53B | -0.77% | 3,267,255 | 2.10B |
| 127 | RGEN | Repligen Corporation | 8.35B | 0.63% | 880,900 | 763.34M |
| 128 | ATR | AptarGroup, Inc. | 8.24B | 0.65% | 466,846 | 3.87B |
| 129 | PCVX | Vaxcyte, Inc. | 8.19B | 0.94% | 857,074 | - |
| 130 | IMVT | Immunovant, Inc. | 8.19B | 2.86% | 754,954 | - |
| 131 | IBRX | ImmunityBio, Inc. | 8.10B | -1.90% | 6,702,001 | 140.98M |
| 132 | TGTX | TG Therapeutics, Inc. | 8.00B | 2.77% | 1,615,954 | 700.35M |
| 133 | HQY | HealthEquity, Inc. | 7.95B | 0.60% | 808,848 | 1.34B |
| 134 | BIO | Bio-Rad Laboratories, Inc. | 7.91B | -0.87% | 250,697 | 2.59B |
| 135 | AVTR | Avantor, Inc. | 7.65B | -0.80% | 10,302,783 | 6.55B |
| 136 | RYTM | Rhythm Pharmaceuticals, Inc. | 7.52B | -0.25% | 404,361 | 217.17M |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 7.38B | 0.09% | 316,557 | 569.61M |
| 138 | PACS | PACS Group, Inc. | 7.12B | 0.11% | 1,310,167 | 5.43B |
| 139 | LQDA | Liquidia Corporation | 6.91B | 1.65% | 848,175 | 288.07M |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.79B | 1.90% | 640,284 | 1.55B |
| 141 | COGT | Cogent Biosciences, Inc. | 6.72B | 2.05% | 2,172,489 | - |
| 142 | HNGE | Hinge Health, Inc. | 6.64B | -3.99% | 1,842,400 | 646.34M |
| 143 | ERAS | Erasca, Inc. | 6.61B | 9.03% | 9,044,043 | - |
| 144 | XENE | Xenon Pharmaceuticals Inc. | 6.55B | 0.61% | 772,030 | 7.50M |
| 145 | PTCT | PTC Therapeutics, Inc. | 6.54B | 1.00% | 1,357,110 | 827.11M |
| 146 | CHE | Chemed Corporation | 6.51B | 0.15% | 123,949 | 2.54B |
| 147 | SRRK | Scholar Rock Holding Corporation | 6.48B | 0.48% | 551,859 | - |
| 148 | CGON | CG Oncology, Inc. | 6.44B | 1.71% | 1,328,737 | 5.07M |
| 149 | GRFS | Grifols, S.A. | 6.22B | 2.71% | 583,403 | 8.58B |
| 150 | DFTX | Definium Therapeutics, Inc. | 6.06B | -0.70% | 1,436,987 | - |
| 151 | BLLN | BillionToOne, Inc. | 5.97B | 4.01% | 683,282 | 354.54M |
| 152 | BLTE | Belite Bio, Inc | 5.88B | 1.90% | 102,801 | - |
| 153 | LGND | Ligand Pharmaceuticals Incorporated | 5.87B | -1.56% | 291,126 | 274.48M |
| 154 | TFX | Teleflex Incorporated | 5.83B | 1.22% | 427,497 | 2.13B |
| 155 | TXG | 10x Genomics, Inc. | 5.81B | -0.09% | 4,747,103 | 638.78M |
| 156 | BLCO | Bausch + Lomb Corporation | 5.80B | 2.01% | 500,796 | 5.21B |
| 157 | TWST | Twist Bioscience Corporation | 5.77B | 0.09% | 1,195,417 | 409.48M |
| 158 | AMRX | Amneal Pharmaceuticals, Inc. | 5.49B | 3.06% | 1,975,179 | 3.05B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 5.46B | -1.35% | 813,826 | 1.34M |
| 160 | TVTX | Travere Therapeutics, Inc. | 5.28B | -0.56% | 801,487 | 536.20M |
| 161 | ORKA | Oruka Therapeutics, Inc. | 5.23B | -0.94% | 825,226 | - |
| 162 | SHC | Sotera Health Company | 5.18B | 2.14% | 2,377,941 | 1.19B |
| 163 | MANE | Veradermics, Incorporated | 5.17B | 12.28% | 1,338,019 | - |
| 164 | STVN | Stevanato Group S.p.A. | 5.16B | -4.64% | 221,823 | 1.39B |
| 165 | CRSP | CRISPR Therapeutics AG | 5.06B | 1.80% | 1,318,800 | 4.10M |
| 166 | INDV | Indivior Pharmaceuticals, Inc. | 4.99B | 1.74% | 1,870,241 | 1.29B |
| 167 | CAI | Caris Life Sciences, Inc. | 4.94B | 3.01% | 6,453,492 | 907.29M |
| 168 | RDNT | RadNet, Inc. | 4.83B | -2.18% | 849,075 | 2.14B |
| 169 | VCYT | Veracyte, Inc. | 4.75B | 5.10% | 908,856 | 541.74M |
| 170 | KNSA | Kiniksa Pharmaceuticals International, plc | 4.75B | -0.47% | 373,094 | 754.05M |
| 171 | CELC | Celcuity Inc. | 4.46B | -17.60% | 8,750,376 | - |
| 172 | LEGN | Legend Biotech Corporation | 4.46B | -10.25% | 5,222,450 | 1.14B |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 4.44B | 1.69% | 1,274,099 | 1.10B |
| 174 | EWTX | Edgewise Therapeutics, Inc. | 4.39B | 2.77% | 1,107,014 | - |
| 175 | VKTX | Viking Therapeutics, Inc. | 4.39B | -0.42% | 1,228,471 | - |
| 176 | TNGX | Tango Therapeutics, Inc. | 4.38B | 2.02% | 2,278,840 | 56.99M |
| 177 | LIVN | LivaNova PLC | 4.36B | 0.37% | 723,368 | 1.43B |
| 178 | MMSI | Merit Medical Systems, Inc. | 4.36B | 2.84% | 661,716 | 1.54B |
| 179 | WAY | Waystar Holding Corp. | 4.35B | 2.25% | 1,527,631 | 1.16B |
| 180 | NVST | Envista Holdings Corporation | 4.35B | 2.30% | 1,781,126 | 2.81B |
| 181 | MMED | MiniMed Group, Inc. | 4.33B | 2.53% | 939,430 | 3.10B |
| 182 | ALHC | Alignment Healthcare, Inc. | 4.33B | -1.27% | 3,142,640 | 4.26B |
| 183 | LFST | LifeStance Health Group, Inc. | 4.25B | 1.67% | 2,969,982 | 1.49B |
| 184 | RLAY | Relay Therapeutics, Inc. | 4.25B | 2.25% | 1,538,023 | 10.68M |
| 185 | DOCS | Doximity, Inc. | 4.07B | 2.11% | 2,332,649 | 644.86M |
| 186 | DYN | Dyne Therapeutics, Inc. | 3.97B | 0.88% | 1,253,633 | - |
| 187 | ICUI | ICU Medical, Inc. | 3.95B | 2.91% | 342,644 | 2.16B |
| 188 | CON | Concentra Group Holdings Parent, Inc. | 3.91B | -1.10% | 880,842 | 2.23B |
| 189 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.85B | - | - | 596.96M |
| 190 | TLX | Telix Pharmaceuticals Limited | 3.81B | 2.45% | 61,910 | 803.79M |
| 191 | PBLS | Parabilis Medicines, Inc. | 3.81B | -3.98% | 463,819 | - |
| 192 | NAMS | NewAmsterdam Pharma Company N.V. | 3.74B | -3.94% | 1,035,329 | 22.57M |
| 193 | IRTC | iRhythm Holdings, Inc. | 3.72B | 0.63% | 383,863 | 787.85M |
| 194 | ELVN | Enliven Therapeutics, Inc. | 3.71B | 2.76% | 500,760 | - |
| 195 | ALMS | Alumis Inc. | 3.67B | 5.61% | 1,495,227 | 8.40M |
| 196 | ADPT | Adaptive Biotechnologies Corporation | 3.67B | 6.86% | 3,986,035 | 295.41M |
| 197 | DNLI | Denali Therapeutics Inc. | 3.65B | 1.63% | 1,889,604 | - |
| 198 | OGN | Organon & Co. | 3.54B | -0.07% | 2,339,617 | 6.16B |
| 199 | PRVA | Privia Health Group, Inc. | 3.54B | 0.25% | 1,145,219 | 2.25B |
| 200 | GPCR | Structure Therapeutics Inc. | 3.53B | -1.92% | 684,483 | - |
| 201 | RCUS | Arcus Biosciences, Inc. | 3.52B | -1.09% | 718,652 | 236.00M |
| 202 | IDYA | IDEAYA Biosciences, Inc. | 3.49B | 0.25% | 580,359 | 225.27M |
| 203 | HAE | Haemonetics Corporation | 3.48B | 3.05% | 534,783 | 1.33B |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 3.47B | 3.62% | 1,508,331 | 415.62M |
| 205 | OPCH | Option Care Health, Inc. | 3.47B | 3.47% | 2,885,513 | 5.67B |
| 206 | WRBY | Warby Parker Inc. | 3.42B | 1.09% | 3,578,330 | 890.57M |
| 207 | BKD | Brookdale Senior Living Inc. | 3.42B | 0.92% | 5,052,621 | 3.00B |
| 208 | NHC | National HealthCare Corporation | 3.38B | 2.55% | 96,653 | 1.53B |
| 209 | ITGR | Integer Holdings Corporation | 3.24B | 2.41% | 461,974 | 1.86B |
| 210 | GRAL | GRAIL, Inc. | 3.19B | 1.70% | 540,153 | 156.12M |
| 211 | RARE | Ultragenyx Pharmaceutical Inc. | 3.11B | -1.00% | 1,012,611 | 670.00M |
| 212 | BEAM | Beam Therapeutics Inc. | 3.07B | -0.16% | 1,395,268 | 164.01M |
| 213 | VERA | Vera Therapeutics, Inc. | 3.05B | -1.46% | 1,802,157 | - |
| 214 | CLDX | Celldex Therapeutics, Inc. | 3.01B | 0.37% | 534,209 | 865.00K |
| 215 | ACHC | Acadia Healthcare Company, Inc. | 2.97B | 2.12% | 3,293,214 | 3.37B |
| 216 | IRON | Disc Medicine, Inc. | 2.90B | 1.35% | 262,389 | - |
| 217 | MBX | MBX Biosciences, Inc. | 2.89B | 7.22% | 1,078,723 | - |
| 218 | QURE | uniQure N.V. | 2.82B | -1.25% | 914,599 | 18.09M |
| 219 | SUPN | Supernus Pharmaceuticals, Inc. | 2.77B | 2.29% | 500,546 | 776.83M |
| 220 | XRAY | DENTSPLY SIRONA Inc. | 2.68B | 5.51% | 5,828,808 | 3.68B |
| 221 | ESTA | Establishment Labs Holdings Inc. | 2.67B | 4.65% | 365,069 | 229.58M |
| 222 | KOD | Kodiak Sciences Inc. | 2.65B | -1.94% | 688,952 | - |
| 223 | TMDX | TransMedics Group, Inc. | 2.61B | 1.06% | 616,702 | 635.89M |
| 224 | IMNM | Immunome, Inc. | 2.60B | 1.46% | 1,899,273 | 4.02M |
| 225 | TRVI | Trevi Therapeutics, Inc. | 2.58B | 1.31% | 1,910,604 | - |
| 226 | RGC | Regencell Bioscience Holdings Limited | 2.54B | -9.29% | 316,723 | - |
| 227 | PGNY | Progyny, Inc. | 2.53B | -0.06% | 1,177,287 | 1.29B |
| 228 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | 0.76% | 240,485 | 1.46B |
| 229 | SLS | SELLAS Life Sciences Group, Inc. | 2.51B | -4.48% | 6,859,911 | - |
| 230 | KLRA | Kailera Therapeutics, Inc. | 2.50B | 1.53% | 285,931 | - |
| 231 | NRIX | Nurix Therapeutics, Inc. | 2.48B | 3.79% | 1,087,611 | 36.77M |
| 232 | TARS | Tarsus Pharmaceuticals, Inc. | 2.47B | 2.48% | 1,467,065 | 535.08M |
| 233 | CLOV | Clover Health Investments, Corp. | 2.46B | -2.90% | 4,674,283 | 2.21B |
| 234 | PHVS | Pharvaris N.V. | 2.46B | 2.15% | 234,437 | - |
| 235 | MLYS | Mineralys Therapeutics, Inc. | 2.41B | 0.11% | 502,433 | - |
| 236 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.39B | -3.39% | 6,813,775 | 885.72M |
| 237 | VCEL | Vericel Corporation | 2.39B | 1.37% | 318,929 | 292.09M |
| 238 | AGIO | Agios Pharmaceuticals, Inc. | 2.37B | -0.13% | 625,036 | 66.05M |
| 239 | MESO | Mesoblast Limited | 2.35B | 8.96% | 488,616 | 65.38M |
| 240 | HTFL | HeartFlow, Inc. | 2.35B | 6.90% | 1,143,112 | 191.42M |
| 241 | ASTH | Astrana Health, Inc. | 2.33B | -4.00% | 571,465 | 3.53B |
| 242 | NKTR | Nektar Therapeutics | 2.31B | 1.68% | 543,480 | 55.63M |
| 243 | ZLAB | Zai Lab Limited | 2.30B | 5.91% | 959,584 | 453.28M |
| 244 | PBH | Prestige Consumer Healthcare Inc. | 2.29B | 2.48% | 397,309 | 1.09B |
| 245 | LMAT | LeMaitre Vascular, Inc. | 2.28B | 1.97% | 224,599 | 256.28M |
| 246 | BHVN | Biohaven Ltd. | 2.24B | -0.54% | 1,310,885 | - |
| 247 | OCUL | Ocular Therapeutix, Inc. | 2.18B | 2.68% | 1,322,841 | 52.04M |
| 248 | PVLA | Palvella Therapeutics, Inc. | 2.18B | 1.53% | 189,671 | - |
| 249 | NEOG | Neogen Corporation | 2.17B | 3.21% | 1,504,973 | 870.56M |
| 250 | OMCL | Omnicell, Inc. | 2.13B | 1.92% | 574,714 | 1.23B |
| 251 | IOVA | Iovance Biotherapeutics, Inc. | 2.12B | 20.61% | 43,697,871 | 285.61M |
| 252 | VRDN | Viridian Therapeutics, Inc. | 2.10B | -0.10% | 1,578,694 | 70.92M |
| 253 | AVAH | Aveanna Healthcare Holdings Inc. | 2.09B | 2.78% | 1,911,756 | 2.52B |
| 254 | SNDX | Syndax Pharmaceuticals, Inc. | 2.08B | -2.53% | 2,282,986 | 217.17M |
| 255 | MD | Pediatrix Medical Group, Inc. | 2.08B | 7.34% | 1,621,930 | 1.93B |
| 256 | AGL | agilon health, inc. | 2.07B | 1.37% | 296,746 | 5.82B |
| 257 | AUPH | Aurinia Pharmaceuticals Inc. | 2.07B | 0.75% | 951,748 | 298.30M |
| 258 | AXGN | Axogen, Inc. | 2.06B | -0.13% | 1,074,399 | 238.11M |
| 259 | SGRY | Surgery Partners, Inc. | 2.06B | 5.09% | 1,420,870 | 3.34B |
| 260 | ABCL | AbCellera Biologics Inc. | 2.06B | - | 3,752,391 | 79.21M |
| 261 | NUVB | Nuvation Bio Inc. | 2.05B | - | 4,540,992 | 143.05M |
| 262 | HCM | HUTCHMED (China) Limited | 2.04B | 3.02% | 65,552 | 548.51M |
| 263 | COAG | Hemab Therapeutics Holdings, Inc. | 2.02B | 0.02% | 307,357 | - |
| 264 | HRMY | Harmony Biosciences Holdings, Inc. | 2.02B | 0.26% | 802,722 | 899.11M |
| 265 | NBTX | Nanobiotix S.A. | 2.02B | -4.03% | 104,563 | 38.27M |
| 266 | ADUS | Addus HomeCare Corporation | 2.01B | 1.54% | 177,514 | 1.45B |
| 267 | ADMA | ADMA Biologics, Inc. | 2.01B | -2.14% | 2,140,514 | 509.86M |
| 268 | SION | Sionna Therapeutics, Inc. | 2.00B | 4.20% | 522,135 | - |
| 269 | TSHA | Taysha Gene Therapies, Inc. | 1.98B | 8.60% | 5,210,751 | 7.47M |
| 270 | GLUE | Monte Rosa Therapeutics, Inc. | 1.98B | -0.21% | 842,628 | 42.95M |
| 271 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.98B | -2.31% | 1,029,964 | -665.00K |
| 272 | ATAI | AtaiBeckley Inc. | 1.97B | -5.47% | 10,867,550 | 3.49M |
| 273 | KARD | Kardigan, Inc. | 1.96B | -1.21% | 334,984 | - |
| 274 | WGS | GeneDx Holdings Corp. | 1.96B | 5.94% | 764,179 | 442.68M |
| 275 | LKFT | Lakefront Biotherapeutics NV | 1.94B | 0.03% | 81,656 | 1.20B |
| 276 | URGN | UroGen Pharma Ltd. | 1.94B | 1.56% | 907,828 | 140.49M |
| 277 | TYRA | Tyra Biosciences, Inc. | 1.93B | -1.52% | 388,744 | - |
| 278 | BFLY | Butterfly Network, Inc. | 1.91B | -5.81% | 12,922,084 | 102.92M |
| 279 | RAPP | Rapport Therapeutics, Inc. | 1.91B | -3.69% | 256,353 | 20.00M |
| 280 | DMRA | Damora Therapeutics, Inc. | 1.91B | -0.13% | 622,554 | - |
| 281 | UFPT | UFP Technologies, Inc. | 1.90B | 6.87% | 280,444 | 608.85M |
| 282 | NEO | NeoGenomics, Inc. | 1.89B | 1.90% | 3,068,689 | 745.97M |
| 283 | STOK | Stoke Therapeutics, Inc. | 1.86B | 2.68% | 592,391 | 32.08M |
| 284 | SRPT | Sarepta Therapeutics, Inc. | 1.86B | -1.95% | 3,508,810 | 2.18B |
| 285 | ZBIO | Zenas BioPharma, Inc. | 1.86B | 2.19% | 611,262 | 10.00M |
| 286 | NVCR | NovoCure Limited | 1.86B | 3.09% | 1,100,967 | 674.41M |
| 287 | BCAX | Bicara Therapeutics Inc. | 1.85B | 0.05% | 258,745 | - |
| 288 | AAPG | Ascentage Pharma Group International | 1.85B | 4.89% | 15,406 | 82.08M |
| 289 | GHRS | GH Research PLC | 1.85B | 0.56% | 141,067 | - |
| 290 | SNDA | Sonida Senior Living, Inc. | 1.83B | -2.12% | 374,438 | 367.34M |
| 291 | BHC | Bausch Health Companies Inc. | 1.83B | 2.95% | 1,625,997 | 10.53B |
| 292 | PGEN | Precigen, Inc. | 1.83B | - | 1,917,884 | 31.60M |
| 293 | NTLA | Intellia Therapeutics, Inc. | 1.82B | -1.95% | 4,026,083 | 66.09M |
| 294 | PLSE | Pulse Biosciences, Inc. | 1.82B | 3.38% | 183,801 | 751.00K |
| 295 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.82B | 8.14% | 4,808,483 | 204.73M |
| 296 | ALMR | Alamar Biosciences, Inc. | 1.81B | -3.40% | 231,193 | 87.16M |
| 297 | GENB | Generate Biomedicines, Inc. | 1.80B | -0.99% | 664,494 | 30.30M |
| 298 | CMPS | COMPASS Pathways plc | 1.80B | -0.60% | 3,358,654 | - |
| 299 | ZYME | Zymeworks Inc. | 1.77B | - | 326,274 | 81.26M |
| 300 | IMCR | Immunocore Holdings plc | 1.76B | 3.62% | 523,626 | 412.81M |
| 301 | RXRX | Recursion Pharmaceuticals, Inc. | 1.76B | -0.90% | 19,429,100 | 66.41M |
| 302 | TDOC | Teladoc Health, Inc. | 1.75B | 4.85% | 5,436,385 | 2.51B |
| 303 | ATRC | AtriCure, Inc. | 1.75B | 0.64% | 505,911 | 552.16M |
| 304 | ANIP | ANI Pharmaceuticals, Inc. | 1.71B | 0.34% | 361,344 | 923.71M |
| 305 | FTRE | Fortrea Holdings Inc. | 1.69B | -0.67% | 974,023 | 2.71B |
| 306 | MPLT | MapLight Therapeutics, Inc. | 1.69B | -1.53% | 703,072 | - |
| 307 | HCSG | Healthcare Services Group, Inc. | 1.67B | 1.58% | 721,583 | 1.85B |
| 308 | TRLV | Trulieve Cannabis Corp. | 1.66B | -4.75% | 715,633 | 1.17B |
| 309 | PSNL | Personalis, Inc. | 1.65B | 5.06% | 5,020,702 | 64.52M |
| 310 | ABSI | Absci Corporation | 1.65B | -4.59% | 3,438,584 | 1.84M |
| 311 | ANAB | AnaptysBio, Inc. | 1.65B | -10.70% | 1,546,208 | 232.39M |
| 312 | MLTX | MoonLake Immunotherapeutics | 1.65B | 2.25% | 1,004,731 | - |
| 313 | MAZE | Maze Therapeutics, Inc. | 1.63B | -1.64% | 346,803 | 20.00M |
| 314 | VIR | Vir Biotechnology, Inc. | 1.62B | 1.26% | 1,225,213 | 65.50M |
| 315 | INVA | Innoviva, Inc. | 1.62B | 0.69% | 1,016,600 | 420.69M |
| 316 | HROW | Harrow, Inc. | 1.60B | 3.77% | 501,136 | 268.68M |
| 317 | INNV | InnovAge Holding Corp. | 1.57B | -0.26% | 292,653 | 949.17M |
| 318 | CDNA | CareDx, Inc. | 1.54B | 2.83% | 619,180 | 412.82M |
| 319 | SEPN | Septerna, Inc. | 1.54B | -1.36% | 373,683 | 72.26M |
| 320 | AVBP | ArriVent BioPharma, Inc. | 1.53B | 1.26% | 314,967 | - |
| 321 | XERS | Xeris Biopharma Holdings, Inc. | 1.50B | 5.07% | 1,440,156 | 314.85M |
| 322 | SVRA | Savara Inc. | 1.47B | 2.11% | 1,035,544 | - |
| 323 | ENOV | Enovis Corporation | 1.47B | 3.81% | 993,979 | 2.28B |
| 324 | IART | Integra LifeSciences Holdings Corporation | 1.46B | 2.07% | 771,963 | 1.64B |
| 325 | INSP | Inspire Medical Systems, Inc. | 1.46B | 2.75% | 679,539 | 915.25M |
| 326 | KMTS | Kestra Medical Technologies, Ltd. | 1.44B | 1.80% | 842,363 | 95.13M |
| 327 | AKTS | Aktis Oncology, Inc. | 1.44B | 3.26% | 435,520 | 8.28M |
| 328 | BLFS | BioLife Solutions, Inc. | 1.42B | 1.75% | 675,866 | 101.66M |
| 329 | STAA | STAAR Surgical Company | 1.42B | 4.24% | 490,071 | 290.38M |
| 330 | OMDA | Omada Health, Inc. | 1.41B | 1.24% | 1,737,195 | 283.30M |
| 331 | AHCO | AdaptHealth Corp. | 1.41B | 3.93% | 1,241,814 | 3.29B |
| 332 | ARDT | Ardent Health, Inc. | 1.40B | - | 669,613 | 6.43B |
| 333 | PRGO | Perrigo Company plc | 1.40B | 2.53% | 2,645,643 | 4.18B |
| 334 | PNTG | The Pennant Group, Inc. | 1.39B | 0.78% | 173,892 | 1.02B |
| 335 | ATEC | Alphatec Holdings, Inc. | 1.39B | 0.78% | 1,327,478 | 787.08M |
| 336 | NVAX | Novavax, Inc. | 1.39B | 0.12% | 2,537,760 | 596.34M |
| 337 | PAHC | Phibro Animal Health Corporation | 1.37B | 2.12% | 288,666 | 1.50B |
| 338 | INBX | Inhibrx Biosciences, Inc. | 1.34B | -2.13% | 208,419 | 1.30M |
| 339 | AHG | Akso Health Group | 1.31B | 0.66% | 3,146 | 14.84M |
| 340 | ARDX | Ardelyx, Inc. | 1.31B | 2.71% | 2,669,684 | 427.68M |
| 341 | JBIO | Jade Biosciences, Inc. | 1.30B | 2.44% | 804,005 | - |
| 342 | IMTX | Immatics N.V. | 1.29B | 1.28% | 477,292 | 43.00M |
| 343 | CNMD | CONMED Corporation | 1.29B | 2.49% | 870,145 | 1.37B |
| 344 | MNKD | MannKind Corporation | 1.26B | 5.41% | 5,611,450 | 360.78M |
| 345 | TRAX | First Tracks Biotherapeutics, Inc. | 1.26B | 5.12% | 486,913 | - |
| 346 | AMN | AMN Healthcare Services, Inc. | 1.25B | -0.46% | 599,982 | 3.42B |
| 347 | CRVS | Corvus Pharmaceuticals, Inc. | 1.25B | -0.33% | 878,139 | - |
| 348 | QDEL | QuidelOrtho Corporation | 1.24B | 3.23% | 1,347,139 | 2.66B |
| 349 | AZTA | Azenta, Inc. | 1.23B | 4.99% | 528,258 | 596.48M |
| 350 | SDGR | Schrödinger, Inc. | 1.22B | 0.87% | 813,987 | 254.91M |
| 351 | AVLN | Avalyn Pharma Inc. | 1.21B | -3.11% | 232,142 | - |
| 352 | NUTX | Nutex Health Inc. | 1.21B | -1.33% | 67,501 | 879.95M |
| 353 | ALVO | Alvotech | 1.21B | 2.42% | 322,819 | 562.04M |
| 354 | IRMD | IRADIMED CORPORATION | 1.20B | 2.13% | 125,542 | 86.28M |
| 355 | COLL | Collegium Pharmaceutical, Inc. | 1.19B | 4.85% | 623,962 | 796.33M |
| 356 | AORT | Artivion, Inc. | 1.18B | 5.10% | 533,919 | 458.69M |
| 357 | CAPR | Capricor Therapeutics, Inc. | 1.18B | -1.60% | 1,371,340 | 11.13M |
| 358 | AVNS | Avanos Medical, Inc. | 1.17B | 0.16% | 291,132 | 715.90M |
| 359 | MGTX | MeiraGTx Holdings plc | 1.16B | 0.96% | 632,032 | 79.76M |
| 360 | EYPT | EyePoint, Inc. | 1.16B | 0.87% | 1,484,510 | 7.61M |
| 361 | ORIC | ORIC Pharmaceuticals, Inc. | 1.15B | 5.59% | 1,778,133 | - |
| 362 | WVE | Wave Life Sciences Ltd. | 1.14B | -3.59% | 1,418,186 | 71.80M |
| 363 | DRTS | Alpha Tau Medical Ltd. | 1.12B | 0.97% | 669,342 | - |
| 364 | XNCR | Xencor, Inc. | 1.11B | 0.20% | 487,640 | 97.36M |
| 365 | CERT | Certara, Inc. | 1.10B | 5.85% | 2,593,527 | 419.75M |
| 366 | CGEM | Cullinan Therapeutics, Inc. | 1.10B | 0.34% | 505,152 | - |
| 367 | SPTX | Seaport Therapeutics, Inc. | 1.09B | 0.05% | 72,500 | - |
| 368 | PRCT | PROCEPT BioRobotics Corporation | 1.09B | -0.83% | 2,392,001 | 322.02M |
| 369 | GMRS | GMR Solutions Inc. | 1.09B | -0.36% | 650,633 | 5.83B |
| 370 | USPH | U.S. Physical Therapy, Inc. | 1.09B | 1.97% | 167,341 | 787.69M |
| 371 | ANRO | Alto Neuroscience, Inc. | 1.08B | 0.07% | 422,439 | - |
| 372 | FBRX | Forte Biosciences, Inc. | 1.08B | 2.20% | 631,370 | - |
| 373 | ANNX | Annexon, Inc. | 1.06B | 17.12% | 8,846,423 | - |
| 374 | SANA | Sana Biotechnology, Inc. | 1.06B | -0.56% | 2,116,311 | - |
| 375 | LMRI | Lumexa Imaging Holdings, Inc. | 1.06B | 1.01% | 794,762 | 1.03B |
| 376 | ETON | Eton Pharmaceuticals, Inc. | 1.05B | 2.64% | 607,364 | 86.93M |
| 377 | TNDM | Tandem Diabetes Care, Inc. | 1.05B | -1.67% | 1,381,875 | 1.03B |
| 378 | IVA | Inventiva S.A. | 1.05B | 1.59% | 984,952 | 7.94M |
| 379 | GDRX | GoodRx Holdings, Inc. | 1.04B | 1.66% | 724,854 | 787.89M |
| 380 | OLMA | Olema Pharmaceuticals, Inc. | 1.03B | -0.25% | 958,161 | - |
| 381 | CRON | Cronos Group Inc. | 1.03B | -0.36% | 656,873 | 159.54M |
| 382 | BIOA | BioAge Labs, Inc. | 1.01B | -0.35% | 513,096 | 10.32M |
| 383 | KURA | Kura Oncology, Inc. | 1.01B | 0.80% | 1,152,783 | 71.64M |
| 384 | BVS | Bioventus Inc. | 999.91M | 3.55% | 401,372 | 576.30M |
| 385 | PCRX | Pacira BioSciences, Inc. | 996.68M | 1.28% | 537,161 | 734.86M |
| 386 | VOR | Vor Biopharma Inc. | 979.68M | -2.27% | 767,740 | - |
| 387 | JANX | Janux Therapeutics, Inc. | 977.58M | 1.58% | 846,651 | 13.73M |
| 388 | LXRX | Lexicon Pharmaceuticals, Inc. | 977.23M | 3.77% | 4,408,666 | 69.64M |
| 389 | AVTX | Avalo Therapeutics, Inc. | 975.09M | 0.71% | 618,040 | 59.00K |
| 390 | SLDB | Solid Biosciences Inc. | 947.09M | -0.10% | 951,058 | - |
| 391 | PHAR | Pharming Group N.V. | 945.12M | -0.15% | 3,757 | 369.49M |
| 392 | GLAS | Glass House Brands Inc. | 937.53M | -3.50% | 347,140 | 177.68M |
| 393 | DBVT | DBV Technologies S.A. | 935.50M | -1.32% | 142,942 | 5.74M |
| 394 | LBRX | LB Pharmaceuticals Inc | 922.24M | 0.44% | 108,168 | - |
| 395 | GERN | Geron Corporation | 910.96M | 2.90% | 6,178,428 | 196.12M |
| 396 | OPK | OPKO Health, Inc. | 906.11M | -1.64% | 1,789,600 | 581.12M |
| 397 | ABUS | Arbutus Biopharma Corporation | 900.77M | -1.08% | 1,507,577 | 191.45M |
| 398 | INMD | InMode Ltd. | 878.31M | 2.41% | 516,722 | 374.64M |
| 399 | PHAT | Phathom Pharmaceuticals, Inc. | 877.70M | 0.09% | 899,527 | 204.89M |
| 400 | TBPH | Theravance Biopharma, Inc. | 877.45M | 0.06% | 615,439 | 109.78M |
| 401 | TALK | Talkspace, Inc. | 872.74M | -0.19% | 1,464,388 | 238.37M |
| 402 | AMPH | Amphastar Pharmaceuticals, Inc. | 855.40M | 3.14% | 356,090 | 720.53M |
| 403 | AVR | Anteris Technologies Global Corp. | 846.50M | -2.91% | 856,507 | 1.85M |
| 404 | DSGN | Design Therapeutics, Inc. | 844.42M | -1.10% | 396,307 | - |
| 405 | ODTX | Odyssey Therapeutics, Inc. | 825.90M | -0.35% | 189,078 | 1.06M |
| 406 | HSTM | HealthStream, Inc. | 825.33M | -0.60% | 125,560 | 311.78M |
| 407 | REPL | Replimune Group, Inc. | 812.59M | -1.93% | 1,578,945 | - |
| 408 | FTH | Faeth Therapeutics, Inc. | 811.26M | -4.98% | 568,208 | - |
| 409 | CTMX | CytomX Therapeutics, Inc. | 801.15M | 0.55% | 5,145,798 | 35.54M |
| 410 | CLYM | Climb Bio, Inc. | 794.20M | 4.76% | 974,939 | - |
| 411 | OCS | Oculis Holding AG | 792.29M | 1.47% | 236,802 | 1.40M |
| 412 | NGNE | Neurogene Inc. | 786.12M | 0.95% | 181,688 | 925.00K |
| 413 | TENX | Tenax Therapeutics, Inc. | 783.75M | -1.41% | 979,815 | - |
| 414 | ACRS | Aclaris Therapeutics, Inc. | 782.12M | 3.13% | 6,078,070 | 8.37M |
| 415 | AURA | Aura Biosciences, Inc. | 773.20M | 0.14% | 308,838 | - |
| 416 | ZVRA | Zevra Therapeutics, Inc. | 766.13M | -0.77% | 871,759 | 122.29M |
| 417 | SIBN | SI-BONE, Inc. | 765.03M | 2.01% | 447,373 | 206.22M |
| 418 | RIGL | Rigel Pharmaceuticals, Inc. | 761.92M | 0.02% | 224,187 | 299.77M |
| 419 | BBNX | Beta Bionics, Inc. | 751.31M | - | 1,746,680 | 110.24M |
| 420 | OMER | Omeros Corporation | 750.53M | -1.24% | 1,134,964 | 9.89M |
| 421 | SPRY | ARS Pharmaceuticals, Inc. | 749.74M | -0.79% | 1,838,410 | 98.99M |
| 422 | IMMX | Immix Biopharma, Inc. | 749.63M | -1.40% | 980,800 | - |
| 423 | DRUG | Bright Minds Biosciences Inc. | 741.29M | 2.55% | 297,385 | - |
| 424 | CBLL | CeriBell, Inc. | 736.09M | 1.41% | 290,777 | 95.07M |
| 425 | GYRE | Gyre Therapeutics, Inc. | 731.37M | 3.47% | 40,508 | 117.05M |
| 426 | CSTL | Castle Biosciences, Inc. | 728.53M | 3.89% | 188,233 | 339.92M |
| 427 | MNPR | Monopar Therapeutics Inc. | 728.09M | 8.92% | 177,109 | - |
| 428 | EVO | Evotec SE | 712.79M | -6.07% | 132,647 | 859.03M |
| 429 | CADL | Candel Therapeutics, Inc. | 706.33M | -2.33% | 1,158,298 | - |
| 430 | SSII | SS Innovations International, Inc. | 704.46M | -4.09% | 41,229 | 48.47M |
| 431 | SGP | SpyGlass Pharma, Inc. | 688.73M | 3.05% | 146,386 | - |
| 432 | SLBT | SL Science Holding Limited | 685.29M | -3.42% | 62,258 | - |
| 433 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 673.70M | -4.65% | 468,279 | - |
| 434 | PHR | Phreesia, Inc. | 665.10M | 0.19% | 772,355 | 495.59M |
| 435 | CRMD | CorMedix Inc. | 660.56M | 1.81% | 648,440 | 400.05M |
| 436 | EVH | Evolent Health, Inc. | 660.26M | -5.17% | 2,963,085 | 1.89B |
| 437 | IRWD | Ironwood Pharmaceuticals, Inc. | 658.45M | 0.50% | 1,366,536 | 361.51M |
| 438 | ALLO | Allogene Therapeutics, Inc. | 655.79M | 2.70% | 6,039,901 | 22.00K |
| 439 | RLMD | Relmada Therapeutics, Inc. | 651.37M | - | 985,915 | - |
| 440 | ACHV | Achieve Life Sciences, Inc. | 649.83M | 0.32% | 1,669,082 | - |
| 441 | TCMD | Tactile Systems Technology, Inc. | 645.11M | 3.55% | 181,310 | 343.52M |
| 442 | CERS | Cerus Corporation | 637.17M | 3.58% | 1,083,632 | 216.56M |
| 443 | MDXG | MiMedx Group, Inc. | 636.00M | 1.67% | 1,206,576 | 389.42M |
| 444 | RGNX | REGENXBIO Inc. | 634.34M | -0.16% | 1,197,215 | 87.82M |
| 445 | PRME | Prime Medicine, Inc. | 630.35M | 0.58% | 2,538,027 | 4.03M |
| 446 | AGMB | AgomAb Therapeutics NV | 622.00M | 4.90% | 142,969 | - |
| 447 | NVCT | Nuvectis Pharma, Inc. | 617.59M | 7.11% | 212,762 | - |
| 448 | TECX | Tectonic Therapeutic, Inc. | 613.25M | -6.64% | 240,899 | - |
| 449 | FDMT | 4D Molecular Therapeutics, Inc. | 610.59M | -0.17% | 419,762 | 88.24M |
| 450 | BWAY | BrainsWay Ltd. | 602.67M | 3.04% | 163,924 | 56.22M |
| 451 | CTKB | Cytek Biosciences, Inc. | 600.51M | 0.65% | 559,732 | 204.17M |
| 452 | ANGO | AngioDynamics, Inc. | 598.08M | 11.31% | 1,375,747 | 320.17M |
| 453 | FLGT | Fulgent Genetics, Inc. | 596.70M | 2.69% | 192,293 | 320.35M |
| 454 | MYGN | Myriad Genetics, Inc. | 595.97M | 4.47% | 1,100,550 | 829.00M |
| 455 | DNA | Ginkgo Bioworks Holdings, Inc. | 587.92M | -0.44% | 607,204 | 151.40M |
| 456 | WEAV | Weave Communications, Inc. | 584.81M | -1.08% | 2,000,552 | 248.72M |
| 457 | ALT | Altimmune, Inc. | 579.53M | 1.71% | 2,862,398 | 36.00K |
| 458 | TOI | The Oncology Institute, Inc. | 565.90M | -9.87% | 2,427,419 | 545.76M |
| 459 | NPCE | NeuroPace, Inc. | 552.66M | 2.34% | 73,300 | 99.53M |
| 460 | CTNM | Contineum Therapeutics, Inc. | 546.96M | 0.41% | 150,986 | - |
| 461 | ARVN | Arvinas, Inc. | 534.24M | 0.12% | 471,812 | 89.40M |
| 462 | EIKN | Eikon Therapeutics, Inc. | 532.72M | -3.43% | 219,055 | - |
| 463 | ASMB | Assembly Biosciences, Inc. | 529.72M | -0.11% | 124,814 | 71.10M |
| 464 | TLRY | Tilray Brands, Inc. | 522.46M | - | 3,547,451 | 858.28M |
| 465 | CBIO | Crescent Biopharma, Inc. | 520.70M | 2.35% | 2,189,530 | 11.88M |
| 466 | STTK | Shattuck Labs, Inc. | 519.13M | 7.63% | 3,113,657 | 1.00M |
| 467 | ZURA | Zura Bio Limited | 512.04M | 6.52% | 690,318 | - |
| 468 | KIDS | OrthoPediatrics Corp. | 506.51M | 2.44% | 102,944 | 243.30M |
| 469 | MCTA | Charming Medical Limited | 504.26M | -0.85% | 4,251,392 | 5.42M |
| 470 | VSTM | Verastem, Inc. | 503.52M | 2.87% | 2,083,595 | 49.59M |
| 471 | CTEV | Claritev Corporation | 501.89M | 3.81% | 101,595 | 978.76M |
| 472 | AQST | Aquestive Therapeutics, Inc. | 495.59M | -2.23% | 1,887,166 | 50.27M |
| 473 | RZLT | Rezolute, Inc. | 495.17M | -1.86% | 756,330 | - |
| 474 | SLN | Silence Therapeutics plc | 493.59M | 7.18% | 791,971 | 839.00K |
| 475 | SGMT | Sagimet Biosciences Inc. | 493.40M | 2.96% | 1,529,983 | - |
| 476 | NRC | NRC Health | 488.14M | -1.46% | 57,457 | 138.64M |
| 477 | OCGN | Ocugen, Inc. | 484.09M | - | 3,577,056 | 4.47M |
| 478 | SOPH | SOPHiA GENETICS SA | 484.08M | 1.58% | 258,597 | 81.18M |
| 479 | PROK | ProKidney Corp. | 483.30M | 3.23% | 827,891 | 889.00K |
| 480 | ARTV | Artiva Biotherapeutics, Inc. | 481.99M | 6.10% | 456,242 | 251.00K |
| 481 | PACB | Pacific Biosciences of California, Inc. | 475.22M | 2.00% | 3,552,633 | 160.03M |
| 482 | KYTX | Kyverna Therapeutics, Inc. | 472.99M | -2.02% | 1,286,553 | - |
| 483 | VALN | Valneva SE | 472.22M | 0.29% | 71,653 | 180.25M |
| 484 | CLPT | ClearPoint Neuro, Inc. | 469.94M | -1.82% | 432,059 | 40.61M |
| 485 | SRTA | Strata Critical Medical, Inc. | 468.97M | 2.65% | 654,222 | 228.58M |
| 486 | EDIT | Editas Medicine, Inc. | 466.52M | -3.80% | 1,602,856 | 38.69M |
| 487 | OVID | Ovid Therapeutics Inc. | 464.73M | 1.22% | 1,156,952 | 7.12M |
| 488 | OFIX | Orthofix Medical Inc. | 456.36M | 3.11% | 242,971 | 825.37M |
| 489 | VMD | Viemed Healthcare, Inc. | 455.44M | -0.50% | 295,261 | 286.57M |
| 490 | DCTH | Delcath Systems, Inc. | 455.00M | 0.30% | 315,579 | 90.44M |
| 491 | VREX | Varex Imaging Corporation | 454.76M | 2.08% | 339,482 | 857.50M |
| 492 | SI | Shoulder Innovations, Inc. | 452.51M | 1.07% | 69,868 | 53.89M |
| 493 | CABA | Cabaletta Bio, Inc. | 451.66M | 3.75% | 3,675,470 | - |
| 494 | EVMN | Evommune, Inc. | 448.43M | 3.84% | 861,584 | 10.00M |
| 495 | BNTC | Benitec Biopharma Inc. | 447.29M | 0.31% | 56,928 | - |
| 496 | PRLD | Prelude Therapeutics Incorporated | 442.33M | 1.59% | 211,223 | 16.72M |
| 497 | PRTA | Prothena Corporation plc | 441.34M | -2.43% | 504,691 | 57.94M |
| 498 | CYH | Community Health Systems, Inc. | 436.16M | 0.94% | 3,604,388 | 12.29B |
| 499 | STRO | Sutro Biopharma, Inc. | 430.83M | -0.12% | 442,941 | 99.61M |
| 500 | PBYI | Puma Biotechnology, Inc. | 428.06M | 1.57% | 261,434 | 227.18M |